Curative Intent Therapy in Oligometastatic Lung Cancer with an Unresectable Primary with N3 Nodes: Case Report and Review of the Literature
Lung Cancer Management · 2016
DOI: 10.2217/lmt-2016-0002 ↗Kurz gefasst
Fallbericht in der Zeitschrift Lung Cancer Management, 2016. Verfasst von Vanita Noronha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, India. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, India.
- Department of Pathology, Tata Memorial Hospital, Parel, Mumbai 400012, India.
- Department of Nuclear Medicine, Tata Memorial Hospital, Parel, Mumbai 400012, India.
- Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, India.
Zitieren
APA
Noronha, V., Joshi, A., Patil, V. M., Jandyal, S., Mittal, N., Purandare, N., Agarwal, J., Kadam, N., & Prabhash, K. (2016). Curative Intent Therapy in Oligometastatic Lung Cancer with an Unresectable Primary with N3 Nodes: Case Report and Review of the Literature. Lung Cancer Management. https://doi.org/10.2217/lmt-2016-0002
Vancouver
Noronha V, Joshi A, Patil VM, Jandyal S, Mittal N, Purandare N, et al. Curative Intent Therapy in Oligometastatic Lung Cancer with an Unresectable Primary with N3 Nodes: Case Report and Review of the Literature. Lung Cancer Management. 2016. doi:10.2217/lmt-2016-0002
BibTeX
@article{Noronha2016,
author = {Noronha, Vanita and Joshi, Amit and Patil, Vijay M and Jandyal, Sunny and Mittal, Neha and Purandare, Nilendu and Agarwal, Jaiprakash and Kadam, Nandkumar and Prabhash, Kumar},
title = {Curative Intent Therapy in Oligometastatic Lung Cancer with an Unresectable Primary with N3 Nodes: Case Report and Review of the Literature},
journal = {Lung Cancer Management},
year = {2016},
doi = {10.2217/lmt-2016-0002}
}
EUVIMED